Hanna Nilsson

About

Hanna Nilsson is a leading clinical researcher in urologic oncology, with a focused expertise on surgical outcomes and patient quality of life following prostate cancer treatment. Her major contributions center on the prospective, multicenter LAPPRO trial, where she has systematically compared robot-assisted and open radical prostatectomy. Nilsson’s work has provided critical evidence that both techniques carry a substantial risk for 90-day hospital readmission—a finding cited over 34 times—and has clarified the distinct risks of inguinal versus incisional hernia formation post-surgery, with her 2020 study on this topic accumulating 21 citations. Beyond surgical complications, she has pioneered the investigation of psychological predictors of recovery, demonstrating that negative intrusive thoughts at diagnosis can significantly impair quality of life and elevate anxiety for up to two years after surgery. Her longitudinal study on this subject, though newer, underscores her commitment to holistic patient outcomes. By integrating rigorous surgical data with patient-reported psychological measures, Nilsson’s research offers a comprehensive roadmap for improving both the physical and emotional recovery of men undergoing radical prostatectomy.

Research Focus

Key Achievements

Top Papers

1. 1
   90-Day readmission after radical prostatectomy—a prospective comparison between robot-assisted and open surgery

   34 citations · 2019
2. 2
   Risk of hernia formation after radical prostatectomy: a comparison between open and robot-assisted laparoscopic radical prostatectomy within the prospectively controlled LAPPRO trial

   21 citations · 2020
3. 3
   Do negative intrusive thoughts at diagnosis predict impaired quality of life, depressed mood and waking up with anxiety 3, 12 and 24 months after radical prostatectomy? – a longitudinal study

   6 citations · 2020

Key Collaborators

Contact & Links